Skip to content
Decision-ready map
• Pick a safe first use case: avoid hard thresholds until confounders are handled
• Start with a confounder checklist and a simple relocation workflow
• Prototype an “interference demo” (before/after cosmetics, tattoo, scar, hair)
• Build trust via clear labeling and user prompts (what to do next)
• Scale plan: partner pilots + evidence dossier + postmarket learning loop
(1) What it is
For early-stage innovators, Theme 6 is about choosing a viable wedge: confounders are predictable and visible, so you can create value by building better labeling, better workflows, or better ‘quality gating’ before building a fully new sensor. A safe first use case avoids hard thresholds until confounders are handled; instead, focus on decision support, education, or tools that reduce false alarms and user distrust.
(2) Who it helps
Innovators exploring opportunities in wearables, spectroscopy tools, NIRS monitoring, clinical workflow, or patient-facing guidance—before a full company/regulatory pathway is set.
(3) What evidence exists
Confounders are well-documented: nail polish and dyes alter oximetry; tattoos and cosmetics alter spectral baselines; scars change scattering and DRS-derived parameters. Standards exist for oximeter performance and reference reflectance datasets exist—making it feasible to build ‘confounder-aware’ prototypes and evidence dossiers early.
(4) Translation barriers
Early teams overbuild sensors when the leverage is in workflow and labeling; pilots exclude confounders; prototypes lack quality gating; and scaling plans ignore support burden from confounder-driven failures.
(5) Equity/safety checks
A confounder-aware solution should reduce exclusion: provide alternatives and non-stigmatizing guidance for tattoos/cosmetics/scars; collect minimal data and protect privacy.
(6) Decision questions
• What safe first use case avoids hard gating while still delivering value?
• Can you prototype a confounder-aware workflow (inspect/relocate/quality gate)?
• What minimal evidence can you generate quickly (failure-rate reduction, fewer false alerts)?
• How will you express limits clearly (labeling/UI scripts)?
• What partnerships can provide representative confounder cases early?
(7) Practical next steps
1) Build a 1-page ‘confounder map’ for your use case and a relocation/quality workflow.
2) Prototype an interference demo and measure failure-rate reduction.
3) Create copy-ready labeling and UI prompts (what to do next).
4) Pilot with partners (clinics/programs) and include tattoos/cosmetics/scars by design.
5) Turn results into an evidence dossier for procurement/regulatory discussions.
(8) References
Aggarwal AN, Agarwal R, Dhooria S, et al. Impact of Fingernail Polish on Pulse Oximetry Measurements: A Systematic Review. Respiratory Care. 2023.
https://doi.org/10.4187/respcare.10399
Yeganehkhah M, Dadkhahtehrani T, Bagheri AR, Kachoie A. Effect of Glittered Nail Polish on Pulse Oximetry Measurements in Healthy Subjects. Iran J Nurs Midwifery Res. 2019.
https://doi.org/10.4103/ijnmr.IJNMR_176_17
Hueter L, Schwarzkopf K, Karzai W. Interference of patent blue V dye with pulse oximetry and co-oximetry. Eur J Anaesthesiol. 2005.
https://doi.org/10.1017/S0265021505230818
Howard JD, Moo V, Sivalingam P. Anaphylaxis and other adverse reactions to blue dyes: a case series. Anaesth Intensive Care. 2011.
https://doi.org/10.1177/0310057X1103900221
Piñero A, Illana J, García-Palenciano C, et al. Effect on Oximetry of Dyes Used for Sentinel Lymph Node Biopsy. Arch Surg. 2004.
https://doi.org/10.1001/archsurg.139.11.1204
Poon KWC, Dadour IR, McKinley AJ. In situ chemical analysis of modern organic tattooing inks by micro-Raman spectroscopy. J Raman Spectrosc. 2008.
https://doi.org/10.1002/jrs.1973
Sadura F, Wróbel MS, Karpienko K. Colored Tattoo Ink Screening Method with Optical Tissue Phantoms and Raman Spectroscopy. Materials (Basel). 2021.
https://doi.org/10.3390/ma14123147
Tseng S-H, Hsu C-K, Lee JY-Y, et al. Noninvasive evaluation of collagen and hemoglobin in keloid scars using DRS. J Biomed Opt. 2012.
https://doi.org/10.1117/1.JBO.17.7.077005
Hsu C-K, Tzeng S-Y, Yang C-C, et al. Non-invasive evaluation of therapeutic response in keloid scar using diffuse reflectance spectroscopy. Biomed Opt Express. 2015.
https://doi.org/10.1364/BOE.6.000390
Yoshida K, Okiyama N. Estimation of reflectance/transmittance/absorbance of cosmetic foundation layer on skin. Opt Express. 2021.
https://doi.org/10.1364/oe.442219
Mancuso A, d’Avanzo ND, Cristiano MC, Paolino D. Reflectance spectroscopy to explore skin reactions to topical products. Front Chem. 2024.
https://doi.org/10.3389/fchem.2024.1422616
Kim KB, Baek HJ. Photoplethysmography in Wearable Devices: A Comprehensive Review. Electronics. 2023.
https://doi.org/10.3390/electronics12132923
Cooksey CC, Allen DW, Tsai BK. Reference Data Set of Human Skin Reflectance. J Res Natl Inst Stan. 2017.
https://doi.org/10.6028/jres.122.026
Cooksey CC, Allen DW, Tsai BK. Reference Data Set of Human Skin Reflectance (data). NIST. 2017.
https://doi.org/10.18434/M38597
IEC. ISO 80601-2-61:2026 Pulse oximeter equipment — safety and essential performance.
https://webstore.iec.ch/en/publication/74527